Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
CWBK Quote, Financials, Valuation and Earnings
Last price:
$34.45
Seasonality move
:
4.89%
Day range:
$34.45 - $34.45
52-week range:
$29.51 - $37.75
Dividend yield:
2.67%
P/E ratio:
8.70x
P/S ratio:
2.38x
P/B ratio:
1.18x
Volume:
--
Avg. volume:
512
1-year change:
7.66%
Market cap:
$102.8M
Revenue:
$47.1M
EPS (TTM):
$4.12
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $24.8M | $33.2M | $34.3M | $43.4M | $47.1M | |
| Revenue Growth (YoY) | 5.35% | 34.26% | 3.28% | 26.34% | 8.56% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.5M | $10M | $9.2M | $10.9M | $11.9M | |
| Other Inc / (Exp) | -$19K | -$14K | -- | -- | -$166K | |
| Operating Expenses | $9.5M | $10M | $9.2M | $10.9M | $11.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $10.7M | $12.2M | $18.6M | $24.1M | $24.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.5M | $3.2M | $4.4M | $6.7M | $6.7M | |
| Net Income to Company | $8.2M | $9.1M | $14.2M | $17.4M | $17.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.2M | $9.1M | $14.2M | $17.4M | $17.6M | |
| Basic EPS (Cont. Ops) | $2.24 | $2.55 | $4.04 | $5.14 | $5.46 | |
| Diluted EPS (Cont. Ops) | $2.14 | $2.48 | $3.95 | $5.00 | $5.39 | |
| Weighted Average Basic Share | $3.7M | $3.6M | $3.5M | $3.4M | $3.2M | |
| Weighted Average Diluted Share | $3.8M | $3.7M | $3.6M | $3.5M | $3.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $15.1M | $14.2M | $20.6M | $28.1M | $35.8M | |
| Revenue (Reported) | $24.8M | $33.2M | $34.3M | $43.4M | $47.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $15.1M | $14.2M | $20.6M | $28.1M | $35.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3M | $9.9M | $11.1M | $10.3M | $11.3M | |
| Revenue Growth (YoY) | 25.22% | 19.6% | 11.9% | -6.98% | -0.5% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4M | $2.5M | $2.8M | $2.9M | $3.3M | |
| Other Inc / (Exp) | -- | -- | -$166K | -- | -- | |
| Operating Expenses | $2.4M | $2.5M | $2.8M | $2.9M | $3.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.8M | $5.6M | $6.2M | $4.2M | $4.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2M | $1.6M | $1.6M | $1.2M | $1.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.6M | $4.1M | $4.6M | $3M | $2.9M | |
| Basic EPS (Cont. Ops) | $1.02 | $1.18 | $1.40 | $0.97 | $0.98 | |
| Diluted EPS (Cont. Ops) | $0.99 | $1.15 | $1.37 | $0.96 | $0.97 | |
| Weighted Average Basic Share | $3.6M | $3.4M | $3.3M | $3.1M | $3M | |
| Weighted Average Diluted Share | $3.7M | $3.5M | $3.4M | $3.1M | $3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.2M | $6.3M | $8.3M | $7.3M | $7.5M | |
| Revenue (Reported) | $8.3M | $9.9M | $11.1M | $10.3M | $11.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.2M | $6.3M | $8.3M | $7.3M | $7.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $35M | $36M | $44.6M | $46.3M | $44.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10M | $10.3M | $11.3M | $11.9M | $12.1M | |
| Other Inc / (Exp) | -- | -- | -$166K | -- | -- | |
| Operating Expenses | $10M | $10.3M | $11.3M | $11.9M | $12.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $15.9M | $19.4M | $24.7M | $22.3M | $17M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.2M | $4.8M | $6.7M | $6.3M | $4.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $11.6M | $14.6M | $17.9M | $16M | $12.1M | |
| Basic EPS (Cont. Ops) | $3.28 | $4.19 | $5.36 | $5.03 | $4.01 | |
| Diluted EPS (Cont. Ops) | $3.18 | $4.06 | $5.22 | $4.97 | $3.96 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $17.4M | $21.7M | $30.2M | $34.8M | $30.9M | |
| Revenue (Reported) | $35M | $36M | $44.6M | $46.3M | $44.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $17.4M | $21.7M | $30.2M | $34.8M | $30.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3M | $9.9M | $11.1M | $10.3M | $11.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4M | $2.5M | $2.8M | $2.9M | $3.3M | |
| Other Inc / (Exp) | -- | -- | -$166K | -- | -- | |
| Operating Expenses | $2.4M | $2.5M | $2.8M | $2.9M | $3.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.8M | $5.6M | $6.2M | $4.2M | $4.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2M | $1.6M | $1.6M | $1.2M | $1.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.6M | $4.1M | $4.6M | $3M | $2.9M | |
| Basic EPS (Cont. Ops) | $1.02 | $1.18 | $1.40 | $0.97 | $0.98 | |
| Diluted EPS (Cont. Ops) | $0.99 | $1.15 | $1.37 | $0.96 | $0.97 | |
| Weighted Average Basic Share | $3.6M | $3.4M | $3.3M | $3.1M | $3M | |
| Weighted Average Diluted Share | $3.7M | $3.5M | $3.4M | $3.1M | $3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.2M | $6.3M | $8.3M | $7.3M | $7.5M | |
| Revenue (Reported) | $8.3M | $9.9M | $11.1M | $10.3M | $11.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.2M | $6.3M | $8.3M | $7.3M | $7.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $359.5M | $638.5M | $398.1M | $438.4M | $387.5M | |
| Short Term Investments | $68.5M | $76.8M | $150.5M | $124.6M | $110.8M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $428M | $715.4M | $548.6M | $563M | $498.3M | |
| Property Plant And Equipment | $256K | $584K | $5.9M | $5.1M | $4.4M | |
| Long-Term Investments | $68.5M | $77.3M | $178.2M | $176.2M | $161.4M | |
| Goodwill | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $883.3M | $1.3B | $1.4B | $1.4B | $1.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | -- | -- | $50M | $50M | $50M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $818.5M | $1.2B | $1.3B | $1.4B | $1.2B | |
| Common Stock | $16.7M | $13.9M | $14.7M | $14M | $12.9M | |
| Other Common Equity Adj | $1.5M | $3.4M | $2.2M | -$11.8M | -$9.1M | |
| Common Equity | $64.9M | $70.2M | $73.5M | $69.6M | $78.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $64.9M | $70.2M | $73.5M | $69.6M | $78.9M | |
| Total Liabilities and Equity | $883.3M | $1.3B | $1.4B | $1.4B | $1.3B | |
| Cash and Short Terms | $428M | $715.4M | $548.6M | $563M | $498.3M | |
| Total Debt | -- | -- | $50M | $50M | $50M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $413.1M | $291.5M | $191.9M | $203.3M | $160M | |
| Short Term Investments | $75.4M | $139.4M | $104.7M | $110.7M | $135.2M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $488.5M | $430.9M | $296.6M | $313.9M | $295.1M | |
| Property Plant And Equipment | $924K | $5.7M | $4.9M | $4.2M | $3.3M | |
| Long-Term Investments | $76.5M | $181.3M | $155.5M | $152.2M | $161.7M | |
| Goodwill | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.2B | $1.3B | $1.1B | $1.1B | $1.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $32.5M | $50M | $50M | $50M | $50M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.2B | $1.1B | $1B | $1.1B | |
| Common Stock | $13.1M | $8M | $14.3M | $12.6M | $12.4M | |
| Other Common Equity Adj | $2.6M | -$4.8M | -$10.4M | -$9.8M | -$9.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $71.9M | $69.4M | $72.4M | $79M | $87.4M | |
| Total Liabilities and Equity | $1.2B | $1.3B | $1.1B | $1.1B | $1.2B | |
| Cash and Short Terms | $488.5M | $430.9M | $296.6M | $313.9M | $295.1M | |
| Total Debt | $32.5M | $50M | $50M | $50M | $50M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.2M | $9.1M | $14.2M | $17.4M | $17.6M | |
| Depreciation & Amoritzation | $201K | $122K | $164K | $254K | $344K | |
| Stock-Based Compensation | $169K | $91K | $90K | $121K | $225K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8.2M | $15M | $12.7M | $21M | $17.7M | |
| Capital Expenditures | $41K | $274K | $1.1M | $12K | $306K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$27.7M | -$158.7M | -$281.5M | -$47.8M | $87.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.9M | -$3.5M | -$2.8M | -$3M | -$2.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $50M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$2.6M | -$3.4M | -$9.5M | -$5M | -$8.9M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $74.7M | $422.9M | $28.4M | $67.6M | -$156.3M | |
| Beginning Cash (CF) | $302.9M | $358.1M | $637.3M | $396.9M | $437.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $55.1M | $279.2M | -$240.4M | $40.8M | -$51M | |
| Ending Cash (CF) | $358.1M | $637.3M | $396.9M | $437.7M | $386.7M | |
| Levered Free Cash Flow | $8.1M | $14.8M | $11.6M | $21M | $17.4M | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CWBK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CWBK
Sector
P/E ratio
8.70x
12.21x
PEG ratio
--
0.40x
P/B ratio
1.18x
1.11x
Price / LTM sales
2.38x
2.66x
Growth Metrics
CWBK
Sector
Revenue growth
-6.65%
5.12%
Earnings growth
-36.03%
2.63%
Revenue (5-year growth)
14.91%
5.17%
Earnings forecast
--
$0.61
Profitability
CWBK
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
9.87%
5.21%
Return on assets
1.11%
0.97%
Return on equity
16.1%
9.24%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
31
Balance Sheet
CWBK
Sector
Total cash
$364.9M
$451.2M
Short term investments
$110.8M
$220.9M
Total assets
$1.3B
$3.8B
Long term debt
$50M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
